[Federal Register Volume 59, Number 178 (Thursday, September 15, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-22866]


[[Page Unknown]]

[Federal Register: September 15, 1994]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE
Drug Enforcement Administration

 

Controlled Substances: Established Revised 1994 Aggregate 
Production Quotas

AGENCY: Drug Enforcement Administration (DEA), Justice.

ACTION: Notice of final revised aggregate production quotas for 1994.

-----------------------------------------------------------------------

SUMMARY: This interim rule (59 FR 36784, July 19, 1994) which 
established 1994 revised aggregate production quotas for some 
controlled substances in Schedules I and II, as required under the 
Controlled Substances Act (CSA) (21 USC 826), is adopted without 
change.

EFFECTIVE DATE: This order is effective upon September 15, 1994.

FOR FURTHER INFORMATION CONTACT:
Howard McClain, Jr., Chief, Drug & Chemical Evaluation Section, Drug 
Enforcement Administration, Washington, D.C. 20537, Telephone: (202) 
307-7183.

SUPPLEMENTARY INFORMATION: Section 306 of the Controlled Substances Act 
(21 U.S.C. 826) requires the Attorney General to establish aggregate 
production quotas for controlled substances in Schedules I and II each 
year. This responsibility has been delegated to the Administrator of 
the DEA pursuant to section 0.100 of Title 28 of the Code of Federal 
Regulations. The Administrator, in turn, has redelegated this function 
to the Deputy Administrator pursuant to 59 FR 23637 (May 6, 1994).
    On July 19, 1994, an interim rule establishing revised 1994 
aggregate production quotas for certain controlled substances in 
Schedules I and II was published in the Federal Register (59 FR 36784). 
All interested persons were invited to comment on or object to these 
proposed aggregate production quotas on or before August 18, 1994. No 
comments or objections were received. The interim rule is adopted 
without change.
    The Office of Management and Budget has determined that notices of 
aggregate production quotas are not subject to centralized review under 
Executive Order 12866. This action has been analyzed in accordance with 
the principles and criteria contained in Executive Order 12612, and it 
has been determined that this matter does not have sufficient 
federalism implications to warrant the preparation of a Federalism 
Assessment.
    The Deputy Administrator hereby certifies that this action will 
have no significant impact upon small entities whose interests must be 
considered under the Regulatory Flexibility Act, 5 U.S.C. 601, et seq. 
The establishment of annual aggregate production quotas for Schedules I 
and II controlled substances is mandated by law and by international 
treaty obligations. While aggregate production quotas are of primary 
importance to large manufacturers, their impact upon small entities is 
neither negative nor beneficial. Accordingly, the Deputy Administrator 
has determined that this action does not require a regulatory 
flexibility analysis.
    Therefore, under the authority vested in the Attorney General by 
Section 306 of the Controlled Substances Act of 1970 (21 U.S.C. 826), 
delegated to the Administrator of the DEA by section 0.100 of Title 28 
of the Code of Federal Regulations, and redelegated to the Deputy 
Administrator, pursuant to 59 FR 23637 (May 6, 1994), the Deputy 
Administrator hereby orders that the 1994 revised aggregate production 
quotas, expressed in grams of anhydrous base, be established as 
follows:

------------------------------------------------------------------------
                                                             Established
                                                               revised  
                        Basic class                          1994 quotas
                                                              (in grams)
------------------------------------------------------------------------
Schedule I:                                                             
  Cathinone................................................            4
  3,4-Methylenedioxymethamphetamine........................           14
Schedule II:                                                            
  Dextropropoxyphene.......................................  123,398,000
  Hydrocodone..............................................    8,344,000
  Hydromorphone............................................      407,000
  Noroxymorphone (for conversion)..........................    1,781,000
  Phenylacetone (for conversion)...........................    3,352,000
------------------------------------------------------------------------

    Dated: September 9, 1994.
Stephen H. Greene,
Deputy Administrator.
[FR Doc. 94-22866 Filed 9-14-94; 8:45 am]
BILLING CODE 4410-09-M